Canada markets closed

Bayer Aktiengesellschaft (BAYN.DE)

XETRA - XETRA Delayed Price. Currency in EUR
Add to watchlist
28.43+0.01 (+0.04%)
At close: 05:42PM CET
Full screen
Previous Close28.42
Open28.52
Bid28.42 x 28400
Ask28.42 x 2100
Day's Range28.17 - 28.62
52 Week Range24.96 - 61.91
Volume3,854,662
Avg. Volume4,674,698
Market Cap27.93B
Beta (5Y Monthly)0.97
PE Ratio (TTM)N/A
EPS (TTM)-2.99
Earnings DateMay 14, 2024
Forward Dividend & Yield0.11 (0.39%)
Ex-Dividend DateApr 29, 2024
1y Target Est34.70
  • Bloomberg

    Bayer-Backed Boundless Bio Falls 11% After $100 Million IPO

    (Bloomberg) -- Shares of Boundless Bio Inc., a cancer therapeutics maker that counts Bayer AG among its largest investors, fell nearly 11% after raising $100 million in a US initial public offering.Most Read from BloombergTesla’s $25,000 Car Means Tossing Out the 100-Year-Old Assembly LineBankman-Fried Is Sentenced to 25 Years in Prison Over FTX CollapseApple Plans New iPad Pro for May as Production Ramps Up OverseasUBS Banker’s Frustration Exposes Cracks in World of Climate FinanceDubai Is Losi

  • Bloomberg

    Bayer-Backed Drug Maker Boundless Bio Raises $100 Million in IPO

    (Bloomberg) -- Boundless Bio Inc., a cancer therapeutics maker that counts Bayer AG among its largest investors, raised $100 million in a US initial public offering after pricing shares at the midpoint of a marketed range.Most Read from BloombergLondon Insurers Face Baltimore Bridge Payouts Worth BillionsBiden Gains Ground Against Trump in Six Key States, Poll ShowsJapan Amps Up Intervention Threat as Yen Hits Lowest Since 1990Trump’s Net Worth Hits $6.5 Billion, Making Him One of World’s 500 Ri

  • Zacks

    Bayer (BAYRY) Banks on Pipeline Progress Amid Challenges

    Bayer (BAYRY) relies on pipeline candidate elinzanetant and key drugs, Nubeqa and Kerendia, to drive growth amid pipeline and regulatory setbacks.